FBXO32 and lung cancer: Elevated levels of low-grade inflammation are accompanied by a concomitant decrease of myoglobin and increased atrogenes (i.e., MuRF1, Atrogin-1) in lung cancer models, that are involved in skeletal muscle degradation [83].